Thus, the clinical similarities between AOS patients with variants in NOTCH1, DLL4, and RBPJ suggest that the majority of developmental defects associated with RBPJ variants that encode proteins with compromised DNA binding are likely due to decreased NOTCH1 signal strength and not due to an impact on the antagonistic co-repressors. The gene discussed is DLL4; the disease is Adams-Oliver syndrome.